
Nephrodite’s Holly Implantable Dialysis System Selected for FDA TAP Program
Nephrodite’s Holly Implantable Dialysis System Selected for FDA TAP Program, Advancing Path Toward Clinical Development Nephrodite, a medical technology company focused on transforming treatment options for patients with end-stage kidney disease, has announced that its Holly™ implantable continuous dialysis system…












